Rahman S, Alzan H, Laughery J, Bastos R, Ueti M, Suarez C
Sci Rep. 2025; 15(1):7781.
PMID: 40044720
PMC: 11882828.
DOI: 10.1038/s41598-025-91359-4.
Adu O, Lee H, Fruh S, Schoenle M, Weichert W, Flyak A
Proc Natl Acad Sci U S A. 2025; 122(8):e2423460122.
PMID: 39951487
PMC: 11873831.
DOI: 10.1073/pnas.2423460122.
Song B, Frank J, Yun S, Julander J, Mason J, Polejaeva I
Int J Mol Sci. 2025; 26(1.
PMID: 39796052
PMC: 11720029.
DOI: 10.3390/ijms26010195.
Premazzi Papa M, Mantus G, Kabra K, Herrera Gomez C, Ward A, Encinales L
Viruses. 2024; 16(11).
PMID: 39599819
PMC: 11598927.
DOI: 10.3390/v16111704.
Mackin S, Sariol A, Diamond M
Immunol Rev. 2024; 328(1):205-220.
PMID: 39162394
PMC: 11661935.
DOI: 10.1111/imr.13383.
A broadly protective antibody targeting glycoprotein Gn inhibits severe fever with thrombocytopenia syndrome virus infection.
Ren X, Sun J, Kuang W, Yu F, Wang B, Wang Y
Nat Commun. 2024; 15(1):7009.
PMID: 39147753
PMC: 11327358.
DOI: 10.1038/s41467-024-51108-z.
Predicting immune response targets in orthoflaviviruses through sequence homology and computational analysis.
Are V, Roy R, Dhanda S, Neema S, Sahu N, Adithya N
J Mol Model. 2024; 30(8):295.
PMID: 39083139
DOI: 10.1007/s00894-024-06088-8.
Fetal MAVS and type I IFN signaling pathways control ZIKV infection in the placenta and maternal decidua.
Alippe Y, Wang L, Coskun R, Muraro S, Zhao F, Elam-Noll M
J Exp Med. 2024; 221(9.
PMID: 39042188
PMC: 11270594.
DOI: 10.1084/jem.20240694.
The D Gene in CDR H3 Determines a Public Class of Human Antibodies to SARS-CoV-2.
Yuan M, Wilson I
Vaccines (Basel). 2024; 12(5).
PMID: 38793718
PMC: 11126049.
DOI: 10.3390/vaccines12050467.
Identification and characterization of a nonbiological small-molecular mimic of a Zika virus conformational neutralizing epitope.
Castanha P, McEnaney P, Park Y, Bouwer A, Chaves E, Lins R
Proc Natl Acad Sci U S A. 2024; 121(21):e2312755121.
PMID: 38743628
PMC: 11127016.
DOI: 10.1073/pnas.2312755121.
enhancement of Zika virus infection by preexisting West Nile virus antibodies in human plasma-derived immunoglobulins revealed after P2 binding site-specific enrichment.
He Y, Zhong L, Yan H, Virata M, Deng L, Mishra A
Microbiol Spectr. 2024; 12(6):e0075824.
PMID: 38687079
PMC: 11237622.
DOI: 10.1128/spectrum.00758-24.
Characterization of Two Highly Specific Monoclonal Antibodies Targeting the Glycan Loop of the Zika Virus Envelope Protein.
McLaury A, Haun B, To A, Mayerlen L, Medina L, Lai C
Viral Immunol. 2024; 37(3):167-175.
PMID: 38574259
PMC: 11040186.
DOI: 10.1089/vim.2023.0153.
Epitope Mapping of Japanese Encephalitis Virus Neutralizing Antibodies by Native Mass Spectrometry and Hydrogen/Deuterium Exchange.
Adhikari J, Heffernan J, Edeling M, Fernandez E, Jethva P, Diamond M
Biomolecules. 2024; 14(3).
PMID: 38540792
PMC: 10967844.
DOI: 10.3390/biom14030374.
Zika Virus-A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis.
Elliott K, Mattapallil J
Pathogens. 2024; 13(2).
PMID: 38392915
PMC: 10892292.
DOI: 10.3390/pathogens13020177.
Structural Outlier Detection and Zernike-Canterakis Moments for Molecular Surface Meshes-Fast Implementation in Python.
Banach M
Molecules. 2024; 29(1).
PMID: 38202635
PMC: 10779519.
DOI: 10.3390/molecules29010052.
Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies.
Contreras M, Stuart J, Levoir L, Belmont L, Goo L
mBio. 2024; 15(2):e0304823.
PMID: 38193697
PMC: 10865826.
DOI: 10.1128/mbio.03048-23.
Plant-expressed Zika virus envelope protein elicited protective immunity against the Zika virus in immunocompetent mice.
Shin M, Kang H, Shin K, Lee R, Kim K, Min K
Sci Rep. 2023; 13(1):22955.
PMID: 38151523
PMC: 10752873.
DOI: 10.1038/s41598-023-47428-7.
The effect of single mutations in Zika virus envelope on escape from broadly neutralizing antibodies.
Kikawa C, Cartwright-Acar C, Stuart J, Contreras M, Levoir L, Evans M
J Virol. 2023; 97(11):e0141423.
PMID: 37943046
PMC: 10688354.
DOI: 10.1128/jvi.01414-23.
Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses.
Lubow J, Levoir L, Ralph D, Belmont L, Contreras M, Cartwright-Acar C
PLoS Pathog. 2023; 19(10):e1011722.
PMID: 37812640
PMC: 10586629.
DOI: 10.1371/journal.ppat.1011722.
Neutralizing antibodies targeting a novel epitope on envelope protein exhibited broad protection against flavivirus without risk of disease enhancement.
Yen L, Chen H, Ho C, Lin C, Lin Y, Yang Q
J Biomed Sci. 2023; 30(1):41.
PMID: 37316861
PMC: 10265553.
DOI: 10.1186/s12929-023-00938-y.